Table 2.
Clinical characteristics of the patients with aortopathy in regard to the type of aortic valve or to the degree of aortic valve regurgitation.
| Variable∗ | TAV (n = 66) | BAV (n = 30) | p B | AVR ≤ 1 (n = 29) | AVR ≥ 2 (n = 67) | p AI |
|---|---|---|---|---|---|---|
| Age (years) | 59 (28-81) | 58 (33-78) | 0.363 | 59 (37-81) | 58 (28-79) | 0.529 |
| BMI (kg/m2) | 26.8 (16.1-39.9) | 28.1 (18.6-38.1) | 0.226 | 27.4 (16.4-35.7) | 26.8 (19.1-39.9) | 0.395 |
| Males | 41 | 23 | 0.161 | 16/13 | 48/19 | 0.116 |
| Smoking | 22 | 10 | 1.000 | 8/21 | 24/43 | 0.432 |
| Diabetes mellitus | 2 | 5 | 0.018 | 4/25 | 3/64 | 0.107 |
| Hypertension | 47 | 14 | 0.021 | 16/13 | 45/22 | 0.262 |
| CAD | 8 | 10 | 0.014 | 5/24 | 13/54 | 0.803 |
| Ao max (mm) | 55 (40-89) | 53 (45-68) | 0.384 | 52 (41-72) | 55 (40-89) | 0.171 |
| AsAA | 23 | 24 | 3.0E-5 | 12/17 | 35/32 | 0.328 |
| BAV | — | — | — | 12/17 | 18/49 | 0.159 |
| AVR ≥ 2 | 49 | 18 | 0.159 | — | — | — |
∗Chi2 test for qualitative variables and Mann-Whitney test for quantitative variables. TAV: tricuspid aortic valve; BAV: bicuspid aortic valve; AVR: aortic valve regurgitation; BMI: body mass index; CAD: coronary artery disease; Ao max: maximal diameter of aorta; AsAA: ascending aortic aneurysm; pB: BAV patients versus TAV patients; pAI: AVR ≥ 2 patients versus AVR ≤ 1 patients.